Skip to main content
Log in

Haematinics I: Patho-Physiological and Clinical Aspects

  • Review Article
  • Published:
Drugs Aims and scope Submit manuscript

Summary

Iron plays an important role in certain basic physiological processes, particularly the synthesis of haemoglobin and myoglobin. Dietary sources rich in iron are meat, eggs and leafy vegetables. The average human has approximately 4 g of iron, and absorbs about 10 % of the food iron ingested. Increased absorption occurs when iron stores are diminished, and when erythropoiesis is active. For adult males, 1 mg of iron absorbed each day is probably sufficient, but for adult females, 2 mg per day are required, and for pregnant females, 3 to 3.5 mg per day are necessary to meet the increased demands.

Iron deficiency is a common disease in modern society, and is likely to remain so. It is not a definitive diagnosis, but a symptom complex, and in every instance where iron deficiency is demonstrated, a cause must be sought and identified with confidence before treatment is commenced. An adequate history and physical examination are important in reaching this diagnosis; aided by a full blood picture, and, in most instances, a determination of the serum iron level and latent iron binding capacity. A careful menstrual history in iron-deficient women is essential.

Vitamin B12 is synthesised in higher animals indirectly from bacterial sources, and for man to have an adequate vitamin B12 intake, some form of dietary meat and animal products is essential. Hydroxocobalamin is a more efficient therapeutic agent than cyanocobalamin, and should be given by injection. The daily requirement for vitamin B12 for the healthy adult is between 2 and 5 μg, representing up to 70 % of the dietary vitamin. Smaller doses will produce a therapeutic response in deficient states, but will not sustain health. The metabolism of vitamin B12 within the body is complex, and is not as clearly understood as the body’s handling of iron.

In the investigation of a patient with megaloblastic anaemia, the nature, extent and cause of the underlying disorder must be assessed — megaloblastic anaemia is but a symptom, and a definitive diagnosis is required before intelligent treatment is possible. Again, history and physical examination are essential elements in reaching the diagnosis. Peripheral blood cell counts and examination of cell morphology in the peripheral blood and bone marrow will assist the diagnosis. Vitamin B12 deficiency may be diagnosed when low vitamin B12 serum levels have been demonstrated, when methylmalonic acid excretion in the urine is low, and when an optimum response to a standard dose of vitamin B12 is achieved. When vitamin B12 deficiency has been diagnosed, gastric causes should be sought in the first instance, usually by gastroscopy, testing for histamine-fast achlorhydria, and by demonstrating the failure to absorb a radioactive tracer dose of vitamin B12, which is absorbed when the defect is corrected by the addition of intrinsic factor. If a gastric cause cannot be implicated, an intestinal cause of failure of absorption is likely. Dietary inadequacy leading to vitamin B12 deficiency is unusual, except in persons who are entirely vegetarian.

The body’s folates are obtained from plant and animal foodstuffs, particularly liver and yeast, and they exist as polyglutamates of tetrahydrofolate. The dietary requirement (free folate) is between 150 and 200 μg per day.

When a megaloblastic anaemia is demonstrated in the presence of pregnancy, during anticonvulsant therapy for epilepsy, or in the chronic alcoholic, folate deficiency is commonly the underlying cause. However, folate deficiency may be due to inadequate dietary intake, intestinal malabsorption, or an increased requirement due to cellular turnover, and in a number of cases, more than one of these factors may be involved. The diagnosis of folate deficiency requires the exclusion of vitamin B12 deficiency, demonstration of low serum folate, and possibly, a low red cell folate. Here again, the haematological response to a therapeutic dose of folate (200 μg daily, preferably by injection) is an important diagnostic feature.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Beal, R.W.: Radioactive isotopes in the investigation of the anaemic patient. Bulletin of the Postgraduate Committee in Medicine, University of Sydney 20: 29–38 (1964).

    Google Scholar 

  • Beal, R.W.; Firkin, B.G.; Skyring, A.P., and McRae, J.: The anaemia of ulcerative colitis. Gastroenterology 45: 589 (1963).

    PubMed  CAS  Google Scholar 

  • Beal, R.W.; Gizis, E., and Meyer, L.M.: Serum protein binding of vitamin B12. Scandinavian Journal of Haematology, Supplement 10 (1969).

  • Beutler, E.; Fairbanks, V.F., and Fahey, J.L.: Clinical disorders of iron metabolism (Grune and Stratton, New York 1963).

    Google Scholar 

  • Booth, C.C.; Chanarin, L; Anderson, B.B., and Mollin, D.L.: The site of absorption and tissue distribution of orally administered 56Co labelled vitamin B12 in the rat. British Journal of Haematology 3: 253–261 (1957).

    Article  PubMed  CAS  Google Scholar 

  • Booth, C.C. and Mollin, D.L.: The site of absorption of vitamin B12 in man. Lancet 1: 18–21 (1959).

    Article  PubMed  CAS  Google Scholar 

  • Bothwell, T.H.; Pribilla, W.F.; Mebust, W., and Finch, C.A.: Iron metabolism in the pregnant rabbit. Iron transport across the placenta. American Journal of Physiology 193: 615–622 (1958).

    PubMed  CAS  Google Scholar 

  • Chanarin, I.: The megaloblastic anaemias (Blackwell, Oxford 1969).

    Google Scholar 

  • Cooper, B.A.; Paranchych, W., and Lowenstein, L.: Studies on the absorption by guinea pig intestine of cyanocobalamin incubated with intrinsic factor. Journal of Clinical Investigation 41: 370–377 (1962).

    Article  PubMed  CAS  Google Scholar 

  • Glass, G.B.J.: Gastric intrinsic factor and its function in the metabolism of vitamin B12. Physiological Reviews 43: 529–849 (1963).

    PubMed  CAS  Google Scholar 

  • Glass, G.B.J.; Lee, D.H., and Hardy, W.W.: Hydroxocobalamin II. Absorption from the site of injection and uptake by the liver and calf muscle in man. Blood 18: 522–526 (1961).

    PubMed  CAS  Google Scholar 

  • Glass, G.B.J.; Skeggs, H.R.; Lee, D.H.; Jones, E.L., and Hardy, W.W.: Hydroxocobalamin I. Blood levels and urinary excretion of vitamin B12 in man after a single parenteral dose of aqueous hydroxocobalamin, aqueous cyanocobalamin and cyanocobalamin zinc-tannate complex. Blood 18: 511–521 (1961).

    PubMed  CAS  Google Scholar 

  • Gough, J.; Israels, M.C.G., and Bottomley, A.C.: The treatment of vitamin B12 deficiency with a vitamin B12-tannin complex. Lancet 2: 1311–1313 (1964).

    Article  PubMed  CAS  Google Scholar 

  • Granick, S.: Iron metabolism and haemochromatosis. Bulletin of the New York Academy of Medicine 25: 403–428 (1949).

    PubMed  CAS  Google Scholar 

  • Grasbeck, R.: Physiology and pathology of vitamin B12 absorption, distribution and excretion. Advances in Clinical Chemistry 3: 299–366 (1960).

    Article  PubMed  CAS  Google Scholar 

  • Grasbeck, R.: Intrinsic factor and the other vitamin B12 transport proteins. Progress in Hematology 6: 233–260 (1969).

    PubMed  CAS  Google Scholar 

  • Grasbeck, R.; Kantero, I., and Siurala, M.: Influence of calcium ions of vitamin B12 absorption in steatorrhoea and pernicious anaemia. Lancet 1: 234 (1959).

    Article  PubMed  CAS  Google Scholar 

  • Hall, C.A. and Finkler, A.E.: A second vitamin B12 binding substance in human plasma. Biochemica et Biophysica Acta 78: 233–236 (1963).

    CAS  Google Scholar 

  • Hall, C.A. and Finkler, A.E.: The dynamics of transcobalamin II. A vitamin B12 binding substance in plasma. Journal of Laboratory and Clinical Medicine 65: 459–468 (1965).

    PubMed  CAS  Google Scholar 

  • Herbert, V.: Nutritional requirements for vitamin B12 and folic acid. Proceedings of the International Society of Haematology 11(1): 109–119 (1966).

    Google Scholar 

  • Herbert, V.: Diagnostic and prognostic values of measurement of serum vitamin B12 binding proteins. Blood 32: 305–312 (1968).

    PubMed  CAS  Google Scholar 

  • Moore, C.V.: Iron metabolism and nutrition. Harvey Lectures 55: 67–101 (1961).

    PubMed  CAS  Google Scholar 

  • Ronnøv-Jessen, V. and Hansen, J.: The site of absorption of Co58-labelled vitamin B12 in man. An investigation made by intestinal intubation with polyethylene glycol as a marker substance. Blood 25: 224–230 (1965).

    PubMed  Google Scholar 

  • Smith, E. Lester: Vitamin B12, 3rd ed. (Methuen, London 1965).

    Google Scholar 

  • Sunderman, F.W. and Boerner, F.: Normal values in clinical medicine (Saunders, Philadelphia 1949), cited by Beutler et al. (1963).

  • Today’s Drugs: Folic acid and combined iron and folic acid preparations. British Medical Journal 4: 102–103 (1968).

    Google Scholar 

  • Verloop, M.C.: Iron depletion without anaemia; a controversial subject. Blood 36: 657–671 (1970).

    PubMed  CAS  Google Scholar 

  • Waxman, S.; Corcino, J.J., and Herbert, V.: Drugs, toxins and dietary amino acids affecting vitamin B12 or folic acid absorption or utilisation. American Journal of Medicine 48: 599–608 (1970).

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

First of 2 parts (Part II: Clinical Pharmacological and Therapeutic Aspects).

Rights and permissions

Reprints and permissions

About this article

Cite this article

Beal, R.W. Haematinics I: Patho-Physiological and Clinical Aspects. Drugs 2, 190–206 (1971). https://doi.org/10.2165/00003495-197102030-00002

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003495-197102030-00002

Key Words

Navigation